TAG expects to receive these clarifications from the manufacturer by end of this week & aims to reconvene for the final risk-benefit assessment on Wednesday, 3 Nov, the WHO said in an email response to a question by ANI on decision regarding the Emergency Use Listing of Covaxin— ANI (@ANI) October 26, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


